Dynasore: Noncompetitive Dynamin GTPase Inhibitor in Endocytosis and Signal Transduction Studies

Executive Summary: Dynasore is a cell-permeable, noncompetitive inhibitor of dynamin GTPase, with an IC₅₀ of 15 μM, enabling selective inhibition of dynamin1, dynamin2, and Drp1 enzymes (APExBIO product sheet). It acutely blocks dynamin-dependent endocytosis by interfering with GTP hydrolysis, providing a reversible tool for mechanistic studies in diverse cell types (Zheng et al., 2024). Dynasore is insoluble in water/ethanol but dissolves in DMSO ≥16.12 mg/mL, and is stable for months at -20°C. Its application extends to cancer biology, neurodegeneration models, and signal transduction pathway elucidation. The compound's effects are benchmarked in HL-1 cells, neurons, and colorectal cancer tissue models, making it a dependable agent for endocytosis and vesicle trafficking studies.

Biological Rationale

Endocytosis is an essential cellular process involving the internalization of nutrients, membrane proteins, and signaling complexes. Dynamin proteins (dynamin1, dynamin2, Drp1) mediate scission of vesicles from the plasma membrane via GTP hydrolysis. Disrupting dynamin function allows precise interrogation of pathways such as receptor-mediated endocytosis, vesicle trafficking, and cell signaling. In cancer and neurodegenerative diseases, aberrant endocytosis contributes to pathogenesis and progression (Zheng et al., 2024). Tools like Dynasore facilitate mechanistic dissection by offering rapid, selective, and reversible inhibition. This underpins its broad utility in fundamental and translational research settings.

Mechanism of Action of Dynasore

Dynasore acts as a noncompetitive inhibitor of dynamin GTPase activity, with an IC₅₀ of 15 μM under standard assay conditions (APExBIO). It binds to dynamin independently of GTP, blocking the GTP hydrolysis required for vesicle scission. This inhibition is rapid and reversible, enabling acute control of endocytosis in live-cell experiments. Dynasore inhibits dynamin1 (neuronal), dynamin2 (ubiquitous), and Drp1 (mitochondrial fission) isoforms. Its action blocks transferrin uptake and synaptic vesicle recycling, as demonstrated in HL-1 cardiac cells and primary neurons. The compound does not covalently modify dynamin, permitting washout and recovery of function. It does not directly inhibit clathrin or caveolin pathways unless they are dynamin-dependent.

Evidence & Benchmarks

• Dynasore inhibits dynamin-dependent endocytosis with an IC₅₀ of 15 μM in vitro (APExBIO).
• Acute Dynasore treatment blocks transferrin uptake in HL-1 cells within 10–20 minutes (Zheng et al., 2024, DOI).
• Reversible inhibition of synaptic vesicle endocytosis is observed in cultured neurons following addition and washout of Dynasore (APExBIO).
• Dynasore is insoluble in water and ethanol, but soluble in DMSO at ≥16.12 mg/mL, facilitating high-concentration stock preparation (APExBIO).
• In colorectal cancer models, endocytic pathways modulated by dynamin influence bacterial vesicle uptake and tumor colonization (Zheng et al., 2024, DOI).

For further context, the article Fusobacterium nucleatum extracellular vesicles are enriched in colorectal cancer and facilitate bacterial adhesion explores the role of vesicle trafficking in cancer colonization, extending foundational knowledge on endocytosis inhibition by Dynasore. This article provides mechanistic updates beyond general endocytosis reviews by focusing on dynamin-mediated pathways in disease models.

Applications, Limits & Misconceptions

Dynasore is used to study:

• Dynamin-dependent endocytosis in mammalian cells.
• Synaptic vesicle recycling in neuronal models.
• Signal transduction and membrane protein dynamics.
• Cancer cell vesicle uptake and microbial colonization mechanisms.
• Mitochondrial fission and trafficking via Drp1 inhibition.

Its application is limited by:

• Poor solubility in aqueous and ethanol solutions; DMSO is required.
• Potential cytotoxicity at concentrations above 80 μM in some cell types.
• Non-specific effects at high concentrations or prolonged exposure.

Common Pitfalls or Misconceptions

• Dynasore does not inhibit clathrin or caveolin directly; only dynamin-dependent steps are blocked.
• It is not suitable for diagnostic or clinical use—intended for research only (APExBIO).
• Stock solutions in water or ethanol are unstable; always use DMSO for dissolution.
• Washout reverses inhibition; effects are not permanent.
• Not all endocytosis is dynamin-dependent; off-target interpretations may occur without proper controls.

Workflow Integration & Parameters

For optimal results, dissolve Dynasore in DMSO at ≥16.12 mg/mL. Warm to 37°C or sonicate to aid dissolution. Prepare working solutions immediately before use, diluting with cell culture medium to desired concentration (typically 10–80 μM). Store stock at -20°C for several months (APExBIO). Avoid repeated freeze-thaw cycles.

Dynasore is compatible with live-cell imaging, flow cytometry, and functional endocytosis assays. The compound enables reversible, rapid modulation of endocytic flux, supporting time-resolved or washout experimental designs. For comparison, see our in-depth guide on small-molecule endocytosis inhibitors, which contrasts Dynasore’s selectivity and reversibility with irreversible or multi-target agents.

Conclusion & Outlook

Dynasore, distributed by APExBIO, remains a robust, validated tool for dissecting dynamin-dependent endocytosis, vesicle trafficking, and related signaling pathways. Its noncompetitive, reversible inhibition profile facilitates acute, controlled mechanistic studies in diverse research areas, from neurobiology to cancer. Ongoing advances in disease modeling, such as the study of bacterial vesicle uptake in colorectal cancer (Zheng et al., 2024), underscore Dynasore’s continued relevance for pathway dissection and translational research. For detailed protocols and ordering, refer to the official Dynasore product page.